Immuno-oncology is one of the most exciting new developments in cancer research. A deep understanding of important targets like PD-1 and PD-L1 could be the key to unlocking the next blockbuster immunotherapy, kick-starting the body’s own immune response to fight cancer.

Our broad range of Alpha Technology immunoassays are the perfect fit for that research:

•    Reproducible, highly sensitive, no-wash solutions for high-throughput screening and biomarker validation
•    Ready-to-use kits, customizable toolbox reagents, and full custom assay development services
•    Use with our EnVision® and EnSight™ multimode plate readers with Alpha detection capabilities for a complete application solution

There’s no work more important – and now you have the tools to move it forward.